FDA MedWatch Links Fleet’s Sodium Phosphate Products To Kidney Disorder

A recommendation by C.B. Fleet that consumers "follow the special instructions from your doctor exactly" when using oral sodium phosphate products for bowel cleansing was issued May 9 following an FDA safety alert

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet